Azafaros is currently owned by Jeito Capital, through Jeito II, since 2025.

When did Jeito Capital acquire Azafaros?

Jeito Capital acquired Azafaros in 2025 (active for 1 year).

Home/Companies/Biotech/Azafaros

Azafaros

Biotech·

Netherlands·Active·1yr hold

Azafaros is a healthcare company, headquartered in France.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Investor

Jeito Capital

Key facts

HQFrance

SectorHealthcare

Leiden-based biotech developing small-molecule therapies for lysosomal storage disorders; Jeito Capital backed in 2025 as Fund II…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito II

Other portfolio companies in the same fund.

Augustine Therapeutics

Active

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings